— Know what they know.
Not Investment Advice
Also trades as: BTMDW (OTC)

BTMD NASDAQ

biote Corp.
1W: +6.2% 1M: -7.6% 3M: -1.4% YTD: -16.2% 1Y: -48.0% 3Y: -63.6% 5Y: -79.3%
$1.99
-0.08 (-3.86%)
 
Weekly Expected Move ±6.6%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Care Facilities · Alpha Radar Sell · Power 43 · $87.8M mcap · 40M float · 0.652% daily turnover · Short 61% of daily vol

Cash Flow Trends

Operating Cash Flow
$35M -22.2% ▼
5Y CAGR: +5.9%
Capital Expenditures
$5M +22.0% ▲
5Y CAGR: +29.2%
Free Cash Flow
$30M -22.2% ▼
5Y CAGR: +3.8%
Dividends Paid
$2M +63.6% ▲
Buybacks
$3M +39.9% ▲
Net Change in Cash
-$15M +69.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$33M$1M$3M$46K$27M
Depreciation & Amort.$1M$2M$3M$4M$4M
Stock-Based Comp.$0$82M$9M$9M$9M
Change in Working Capital-$1M-$36M-$9M$10M-$8M
Other Non-Cash Items$1M-$58M$20M$26M-$165K
Operating Cash Flow$34M-$9M$27M$45M$35M
— Investing Activities —
Capital Expenditures-$1M-$333K-$359K-$6M-$5M
Acquisitions (Net)$0$0$0-$12M$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$2M-$2M-$2M-$526K-$2M
Investing Cash Flow-$4M-$2M-$3M-$19M-$7M
— Financing Activities —
Net Debt Issuance-$5M$84M-$6M-$6M-$1M
Stock Repurchased$0-$424K$0-$6M-$3M
Dividends Paid-$11M-$13M-$9M-$5M-$2M
Other Financing-$4M-$8M$420K-$60M-$38M
Financing Cash Flow-$20M$63M-$14M-$76M-$44M
Net Change in Cash$10M$52M$10M-$50M-$15M
Cash End of Period$27M$79M$89M$39M$24M
Free Cash Flow$30M-$11M$24M$39M$30M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms